Would a national pharmaceutical strategy be bad for the cardiovascular health of Canadians?
Tu
Jack V
JV
D002170:Canada / Q000453:epidemiology; D002317:Cardiovascular Agents / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000401:mortality; D016527:Drug Costs; D006304:Health Status; D006801:Humans; D010593:Pharmaceutical Services / Q000592:standards*; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends
D002317:Cardiovascular Agents